A DECISION-ANALYTIC APPROACH TO POSTEXPOSURE RABIES PROPHYLAXIS

被引:11
作者
CANTOR, SB
CLOVER, RD
THOMPSON, RF
机构
[1] Department of Family Medicine, University of Texas Medical Branch, Galveston, TX 77555-0853
关键词
D O I
10.2105/AJPH.84.7.1144
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The risks and benefits of postex-posure rabies prophylaxis were analyzed from clinical and economic perspectives. A decision-analytic model was constructed by using probability and outcome data from the literature and the state health department. Health outcomes were measured in quality-adjusted life years. In the base case (overweight adult male), treatment is optimal when the probability of animal rabidity is greater than 1 in 2000. Sensitivity analysis showed robustness in the treatment decision; however, the incremental cost-effectiveness ratio ($140000/quality-adjusted life year) is sensitive to the rabidity probability. Treatment is optimal from the patient's perspective; however, it may not be cost-effective when the probability of rabidity is low.
引用
收藏
页码:1144 / 1148
页数:5
相关论文
共 28 条
[1]  
[Anonymous], 1991, MMWR Recomm Rep, V40, P1
[2]   KNOWING FOR THE SAKE OF KNOWING - THE VALUE OF PROGNOSTIC INFORMATION [J].
ASCH, DA ;
PATTON, JP ;
HERSHEY, JC .
MEDICAL DECISION MAKING, 1990, 10 (01) :47-57
[3]   NEUROPARALYTIC ILLNESS AND HUMAN-DIPLOID CELL RABIES VACCINE [J].
BERNARD, KW ;
SMITH, PW ;
KADER, FJ ;
MORAN, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (23) :3136-3138
[4]   GUILLAIN-BARRE-SYNDROME AFTER VACCINATION WITH HUMAN-DIPLOID CELL RABIES VACCINE [J].
BOE, E ;
NYLAND, H .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1980, 12 (03) :231-232
[5]   HIDDEN ETHICAL ISSUES IN CLINICAL DECISION-ANALYSIS [J].
BRETT, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (19) :1150-1152
[6]  
CANTOR SB, 1991, UNPUB DECISION ANALY
[7]   POINT ESTIMATION OF PARAMETER OF BINOMIAL DISTRIBUTION [J].
CHEW, V .
AMERICAN STATISTICIAN, 1971, 25 (05) :47-&
[8]  
CLEVERLY WO, 1992, 1992 ALMANAC HOSPITA
[9]   IMMUNE COMPLEX-LIKE DISEASE IN 23 PERSONS FOLLOWING A BOOSTER DOSE OF RABIES HUMAN-DIPLOID CELL VACCINE [J].
DREESEN, DW ;
BERNARD, KW ;
PARKER, RA ;
DEUTSCH, AJ ;
BROWN, J .
VACCINE, 1986, 4 (01) :45-49
[10]   RABIES PREVENTION IN PRIMARY CARE - A 4-STEP APPROACH [J].
FISHBEIN, DB ;
ARCANGELI, S .
POSTGRADUATE MEDICINE, 1987, 82 (03) :83-&